Phase 1 14 trials
Phase 1
NCT05818683 Apr 2023 → Aug 2027 expected prostate carcinoma Janssen Research & Development, LLC
Recruiting
No outcome recorded
Phase 1
NCT03878524 Apr → Dec 2020 acute myeloid leukemia , atypical chronic myeloid leukemia, BCR-ABL1 negative , blast phase chronic myelogenous leukemia, BCR-ABL1 positive , castration-resistant prostate carcinoma +14 OHSU Knight Cancer Institute
Terminated
No outcome recorded
Phase 1
NCT03110588 May 2018 → Dec 2019 metastatic prostate carcinoma University of Alabama at Birmingham
Withdrawn
No outcome recorded
Phase 1
NCT01594918 Jun 2012 → Aug 2016 prostate carcinoma Rahul Aggarwal
Completed
No outcome recorded
Phase 1
NCT01527929 Apr 2012 → Nov 2013 cancer Sanofi
Completed
No outcome recorded
Phase 1
NCT01447225 Oct 2011 → Nov 2013 cancer Merrimack Pharmaceuticals
Completed
No outcome recorded
Phase 1
NCT01420250 Sep 2011 → Jul 2015 prostate cancer Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Completed
No outcome recorded
Phase 1
NCT01379339 Apr 2011 → Jan 2015 head and neck squamous cell carcinoma Krzysztof Misiukiewicz
Completed
No outcome recorded
Phase 1
NCT01324583 Jan 2011 → Nov 2014 prostate cancer Sanofi
Completed
No outcome recorded
Phase 1
NCT01140607 May 2010 → Jul 2014 cancer Sanofi
Completed
No outcome recorded
Phase 1
NCT01087021 Mar 2010 → Apr 2011 cancer Sanofi
Completed
No outcome recorded
Phase 1
NCT00925743 Jun 2009 → Mar 2013 —
Sanofi
Completed
No outcome recorded
Phase 1
NCT01755390 Oct 1999 → Aug 2002 neoplasm Sanofi
Completed
No outcome recorded
Phase 1
NCT01981668 ? → Sep 2013 prostate neoplasm Nova Scotia Cancer Centre
Withdrawn
No outcome recorded
Show 4 more trials Phase 1/2 11 trials
Phase 1/2
NCT06353386 May 2024 → Jan 2029 expected castration-resistant prostate carcinoma Merck Sharp & Dohme LLC
Recruiting
No outcome recorded
Phase 1/2
NCT05340374 Jul 2022 → Jun 2026 overdue castration-resistant prostate carcinoma Peter MacCallum Cancer Centre, Australia
Active not recruiting
No outcome recorded
Phase 1/2
NCT02522715 Aug 2015 → Oct 2019 overdue castration-resistant prostate carcinoma , metastatic prostate carcinoma OHSU Knight Cancer Institute
Active not recruiting
No outcome recorded
Phase 1/2
NCT02202772 Dec 2014 → Apr 2026 overdue urothelial carcinoma Guarionex J. Decastro
Active not recruiting
No outcome recorded
Phase 1/2
NCT01740570 Apr 2013 → Apr 2017 brain cancer M.D. Anderson Cancer Center
Withdrawn
No outcome recorded
Phase 1/2
NCT01751308 Feb 2013 → Jul 2015 nervous system cancer Sanofi
Completed
No outcome recorded
Phase 1/2
NCT01505868 Jul 2012 → Dec 2019 castration-resistant prostate carcinoma , lymph node disorder , metastatic carcinoma in the bone , metastatic prostate carcinoma +2 M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 1/2
NCT01511536 Mar 2012 → Jul 2014 prostate cancer Sanofi
Completed
No outcome recorded
Phase 1/2
NCT01497964 Dec 2011 → May 2013 gastric cancer Sanofi
Completed
No outcome recorded
Phase 1/2
NCT01335204 Jun 2011 → Mar 2013 prostate cancer Medical University of South Carolina
Terminated
No outcome recorded
Phase 1/2
NCT01001221 Nov 2009 → Oct 2011 cancer Sanofi
Terminated
No outcome recorded
Show 1 more trial Phase 2 62 trials
Phase 2
NCT06738303 Jul 2025 → Dec 2026 expected castration-resistant prostate carcinoma , metastatic prostate carcinoma Case Comprehensive Cancer Center
Recruiting
No outcome recorded
Phase 2
NCT06890832 May 2025 → Dec 2026 expected castration-resistant prostate carcinoma Jina Pharmaceuticals Inc.
Not yet recruiting
No outcome recorded
Phase 2
NCT06632977 Feb 2025 → Apr 2030 expected castration-resistant prostate carcinoma Alliance for Clinical Trials in Oncology
Recruiting
No outcome recorded
Phase 2
NCT05563558 May 2023 → Nov 2026 expected metastatic prostate carcinoma Fundacion Oncosur
Recruiting
No outcome recorded
Phase 2
NCT05005728 Oct 2021 → Jun 2025 castration-resistant prostate carcinoma Xencor, Inc.
Completed
No outcome recorded
Phase 2
NCT04709276 Jun 2021 → Feb 2026 overdue metastatic prostate carcinoma , prostate neuroendocrine neoplasm Andrew J. Armstrong, MD
Active not recruiting
No outcome recorded
Phase 2
NCT04622761 Jan 2021 → Nov 2025 prostate cancer The Clatterbridge Cancer Centre NHS Foundation Trust
Unknown
No outcome recorded
Phase 2
NCT04592237 Dec 2020 → Dec 2027 expected castration-resistant prostate carcinoma , metastatic prostate carcinoma , prostate small cell carcinoma M.D. Anderson Cancer Center
Active not recruiting
No outcome recorded
Phase 2
NCT04495179 Aug 2020 → Nov 2021 castration-resistant prostate carcinoma AstraZeneca
Completed
No outcome recorded
Phase 2
NCT03934840 Oct 2019 → Jun 2023 prostate cancer Masonic Cancer Center, University of Minnesota
Completed
No outcome recorded
Phase 2
NCT03764540 Apr 2019 → Dec 2024 metastatic prostate carcinoma University of Montreal Hospital Centre (CHUM)
Terminated
No outcome recorded
Phase 2
NCT03101046 Nov 2018 → Dec 2021 castration-resistant prostate carcinoma UNICANCER
Completed
No outcome recorded
Phase 2
NCT03419234 Apr 2018 → Jan 2024 overdue castration-resistant prostate carcinoma , metastatic prostate carcinoma , prostate adenocarcinoma ECOG-ACRIN Cancer Research Group
Active not recruiting
No outcome recorded
Phase 2
NCT03257891 Jan 2018 → Jan 2021 adrenal cortex carcinoma Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Unknown
No outcome recorded
Phase 2
NCT02844582 Dec 2017 → Jun 2019 hormone-resistant prostate carcinoma , prostate adenocarcinoma University of California, Davis
Terminated
No outcome recorded
Phase 2
NCT03356912 Nov 2017 → May 2021 castration-resistant prostate carcinoma Consorzio Oncotech
Unknown
No outcome recorded
Phase 2
NCT03263650 Oct 2017 → Jun 2026 prostate cancer aggressiveness quantitative trait locus on chromosome 19 , prostate carcinoma M.D. Anderson Cancer Center
Completed
No outcome recorded
Phase 2
NCT02985957 Mar 2017 → Apr 2022 prostate cancer Bristol-Myers Squibb
Completed
No outcome recorded
Phase 2
NCT03050866 Feb 2017 → Jan 2022 metastatic prostate carcinoma Erasmus Medical Center
Unknown
No outcome recorded
Phase 2
NCT02903160 Jan 2017 → Nov 2021 prostate cancer Icahn School of Medicine at Mount Sinai
Completed
No outcome recorded
Phase 2
NCT02543255 Sep 2016 → May 2021 prostate cancer University Health Network, Toronto
Completed
No outcome recorded
Phase 2
NCT02621190 Feb 2016 → Feb 2019 prostate cancer Erasmus Medical Center
Withdrawn
No outcome recorded
Phase 2
NCT02512458 Oct 2015 → Dec 2019 metastatic prostate carcinoma Hellenic Cooperative Oncology Group
Completed
No outcome recorded
Phase 2
NCT02560337 Sep 2015 → Dec 2018 ovarian cancer Vejle Hospital
Completed
No outcome recorded
Phase 2
NCT02166658 Aug 2015 → Apr 2017 breast cancer , lung cancer , metastatic malignant neoplasm in the brain AIO-Studien-gGmbH
Terminated
No outcome recorded
Phase 2
NCT02379390 Jun 2015 → May 2018 metastatic prostate carcinoma Sanofi
Terminated
No outcome recorded
Phase 2
NCT02478502 Jun 2015 → Dec 2022 testicular cancer University Hospital, Akershus
Terminated
No outcome recorded
Phase 2
NCT03114254 Dec 2014 → Nov 2016 penile carcinoma University Hospitals Bristol and Weston NHS Foundation Trust
Completed
No outcome recorded
Phase 2
NCT03048942 Nov 2014 → Aug 2025 Her2-receptor negative breast cancer University Hospitals Bristol and Weston NHS Foundation Trust
Unknown
No outcome recorded
Phase 2
NCT01913652 Oct 2014 → Dec 2020 dedifferentiated liposarcoma European Organisation for Research and Treatment of Cancer - EORTC
Completed
No outcome recorded
Phase 2
NCT02254785 Oct 2014 → May 2020 castration-resistant prostate carcinoma British Columbia Cancer Agency
Unknown
No outcome recorded
Phase 2
NCT02218606 Aug 2014 → Oct 2023 prostate cancer Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 2
NCT02115165 Jul 2014 → Apr 2022 nongerminomatous germ cell tumor Gustave Roussy, Cancer Campus, Grand Paris
Completed
No outcome recorded
Phase 2
NCT01934894 May 2014 → Feb 2016 metastatic malignant neoplasm in the brain SCRI Development Innovations, LLC
Terminated
No outcome recorded
Phase 2
NCT02035124 Apr 2014 → Jan 2015 prostate cancer SCRI Development Innovations, LLC
Withdrawn
No outcome recorded
Phase 2
NCT01866449 Oct 2013 → Dec 2016 glioblastoma University of Ulm
Completed
No outcome recorded
Phase 2
NCT01956149 Sep 2013 → Dec 2017 gastric cancer Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Completed
No outcome recorded
Phase 2
NCT01913067 Sep 2013 → May 2016 breast cancer , metastatic malignant neoplasm in the brain , non-small cell lung carcinoma Jules Bordet Institute
Withdrawn
No outcome recorded
Phase 2
NCT01845792 Jul 2013 → Feb 2017 prostate cancer University of Colorado, Denver
Terminated
No outcome recorded
Phase 2
NCT01941550 Jul 2013 → Jan 2016 neoplastic disease or syndrome RWTH Aachen University
Terminated
No outcome recorded
Phase 2
NCT01718353 Mar 2013 → Aug 2015 metastatic prostate carcinoma Sanofi
Completed
No outcome recorded
Phase 2
NCT02204332 Mar → Sep 2013 colorectal cancer Hospital Clinico Universitario de Santiago
Terminated
No outcome recorded
Phase 2
NCT01779479 Feb 2013 → Aug 2015 breast cancer GBG Forschungs GmbH
Completed
No outcome recorded
Phase 2
NCT01750866 Feb → Oct 2013 prostate carcinoma Case Comprehensive Cancer Center
Withdrawn
No outcome recorded
Phase 2
NCT01747239 Jan 2013 → Jul 2014 ovarian cancer Vejle Hospital
Terminated
No outcome recorded
Phase 2
NCT01650285 Jan 2013 → Jul 2014 prostate cancer Brown University
Terminated
No outcome recorded
Phase 2
NCT01757171 Dec 2012 → Jul 2016 esophageal adenocarcinoma , gastric adenocarcinoma , gastroesophageal adenocarcinoma Weill Medical College of Cornell University
Completed
No outcome recorded
Phase 2
NCT01693549 Sep 2012 → Jul 2017 breast cancer Hellenic Cooperative Oncology Group
Completed
No outcome recorded
Phase 2
NCT01852578 Sep 2012 → Aug 2013 non-small cell lung carcinoma Hellenic Oncology Research Group
Completed
No outcome recorded
Phase 2
NCT01576029 Aug 2012 → Dec 2013 prostate neoplasm Sanofi
Completed
No outcome recorded
Phase 2
NCT01616875 Jul 2012 → Nov 2017 infiltrating bladder urothelial carcinoma University Hospitals Bristol and Weston NHS Foundation Trust
Completed
No outcome recorded
Phase 2
NCT01518283 May 2012 → Jun 2016 hormone-resistant prostate carcinoma Spanish Oncology Genito-Urinary Group
Completed
No outcome recorded
Phase 2
NCT01531205 May 2012 → Sep 2013 prostate cancer H. Lee Moffitt Cancer Center and Research Institute
Terminated
No outcome recorded
Phase 2
NCT01600339 May 2012 → Jan 2015 urothelial carcinoma Rambam Health Care Campus
Completed
No outcome recorded
Phase 2
NCT01620242 Apr 2012 → Jun 2013 head and neck cancer UNICANCER
Completed
No outcome recorded
Phase 2
NCT01541007 Apr 2012 → Oct 2015 castration-resistant prostate carcinoma Jeffrey Yachnin M.D., PhD.
Completed
No outcome recorded
Phase 2
NCT01500720 Mar 2012 → Apr 2014 small cell lung carcinoma Sanofi
Completed
No outcome recorded
Phase 2
NCT01437488 Feb 2012 → Aug 2014 urothelial carcinoma Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Completed
No outcome recorded
Phase 2
NCT01528163 Feb 2012 → Nov 2014 head and neck squamous cell carcinoma Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Completed
No outcome recorded
Phase 2
NCT01558219 Nov 2011 → Dec 2014 metastatic prostate carcinoma Tampere University Hospital
Completed
No outcome recorded
Phase 2
NCT01438307 Sep 2011 → Sep 2014 non-small cell lung carcinoma University of Alabama at Birmingham
Completed
No outcome recorded
Phase 2
NCT01365130 Jun 2011 → Dec 2012 esophageal disorder , gastric cancer , gastroesophageal cancer Howard Safran
Terminated
No outcome recorded
Show 52 more trials Phase 2/3 3 trials
Phase 2/3
NCT03258320 Jan 2015 → Dec 2026 expected prostate cancer Shanghai Jiao Tong University School of Medicine
Recruiting
No outcome recorded
Phase 2/3
NCT01668459 Jan 2013 → Nov 2017 transitional cell carcinoma Dr Anjali Zarkar
Completed
No outcome recorded
Phase 2/3
NCT01830231 Oct 2012 → Nov 2016 urothelial carcinoma Associació per a la Recerca Oncologica, Spain
Unknown
No outcome recorded
Phase 3 8 trials
Phase 3
NCT02961257 May 2017 → Dec 2021 metastatic prostate carcinoma Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie
Completed
No outcome recorded
Phase 3
NCT02044354 May 2014 → Apr 2017 prostate carcinoma Gustave Roussy, Cancer Campus, Grand Paris
Completed
No outcome recorded
Phase 3
NCT01952223 Dec 2013 → Dec 2025 overdue prostate adenocarcinoma UNICANCER
Active not recruiting
No outcome recorded
Phase 3
NCT01978873 Nov 2012 → Nov 2018 prostate cancer Örebro University, Sweden
Unknown
No outcome recorded
Phase 3
NCT01308567 May 2011 → Sep 2015 prostate cancer Sanofi
Completed
No outcome recorded
Phase 3
NCT01308580 Apr 2011 → Aug 2015 prostate cancer Sanofi
Completed
No outcome recorded
Phase 3
NCT01254279 Dec 2010 → Dec 2014 metastatic prostate carcinoma Sanofi
Completed
No outcome recorded
Phase 3
NCT00417079 Jan 2007 → Sep 2009 prostate neoplasm Sanofi
Completed
No outcome recorded
Phase 4 4 trials
Phase 4
NCT02485691 Nov 2015 → Mar 2019 metastatic prostate carcinoma Sanofi
Completed
No outcome recorded
Phase 4
NCT02441894 Apr 2015 → Feb 2016 prostate cancer Sanofi
Completed
No outcome recorded
Phase 4
NCT02074137 Jul 2014 → Mar 2016 metastatic prostate carcinoma Sanofi
Completed
No outcome recorded
Phase 4
NCT01649635 Jul 2012 → Jan 2014 prostate cancer Sanofi
Completed
No outcome recorded
Phase not applicable 1 trial
— NCT02551718 Sep 2015 → Jun 2020 acute leukemia of ambiguous lineage , acute lymphoblastic leukemia University of Washington
Completed
No outcome recorded